Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis
Proteins: Structure, Function, and Bioinformatics · 2025
DOI: 10.1002/prot.26684 ↗At a glance
Journal article in Proteins: Structure, Function, and Bioinformatics, 2025. Written by Aadam Basrai and 2 co-authors. Institution: Victor Phillip Dahdaleh Heart and Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK. Major MEDLINE topics: Mycobacterium tuberculosis, Bacterial Proteins, Isoniazid, Antitubercular Agents. Cited 1 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Cystic Fibrosis Trust.
Abstract (original language)
The number of antibiotic resistant pathogens is increasing rapidly, and with this comes a substantial socioeconomic cost that threatens much of the world. To alleviate this problem, we must use antibiotics in a more responsible and informed way, further our understanding of the molecular basis of drug resistance, and design new antibiotics. Here, we focus on a key drug‐resistant pathogen, Mycobacterium tuberculosis , and computationally analyze trends in drug‐resistant mutations in genes of the proteins embA , embB , embC , and katG , which play essential roles in the action of the first‐line drugs ethambutol and isoniazid. We use docking to predict binding modes of isoniazid to katG that agree with suggested binding sites found in our laboratory using cryo‐EM. Using mutant stability predictions, we recapitulate the idea that resistance occurs when katG's heme cofactor is destabilized rather than due to a decrease in affinity to isoniazid. Conversely, we have identified resistance mutations that affect the affinity of ethambutol more drastically than the affinity of the natural substrate of embB . With this, we illustrate that we can distinguish between the two types of drug resistance—cofactor destabilization and drug affinity reduction—suggesting potential uses in the prediction of novel drug‐resistant mutations.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Victor Phillip Dahdaleh Heart and Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK.
ORCID profiles: Arun Prasad Pandurangan
Funding
- Wellcome Trust
- Cystic Fibrosis Trust
Cite
APA
Basrai, A., Blundell, T. L., & Pandurangan, A. P. (2025). Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26684
Vancouver
Basrai A, Blundell TL, Pandurangan AP. Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis. Proteins: Structure, Function, and Bioinformatics. 2025. doi:10.1002/prot.26684
BibTeX
@article{Basrai2025,
author = {Basrai, Aadam and Blundell, Tom L and Pandurangan, Arun Prasad},
title = {Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis},
journal = {Proteins: Structure, Function, and Bioinformatics},
year = {2025},
doi = {10.1002/prot.26684}
}
EUVIMED